Elevance Health Inc.

(New York Stock Exchange)
Back to all articles
Neutral 0

Elevance Health Inc. stock outperforms competitors despite losses on the day

AI-generated analysis

πŸ“‰ Elevance Health Inc. stock declined 2.67% to close at $286.39 on Friday amid a broad market downturn.

πŸ“Š The broader S&P 500 Index fell 1.67% to 6,368.85 and the Dow Jones Industrial Average dropped 1.73% to 45,166.64.

⏳ This represents Elevance Health's second consecutive day of losses.

Bullish Signals
  • Elevance Health Inc. (ELV) outperformed competitors on the day despite a loss, demonstrating resilience in a challenging market environment.
  • The stock showed relative strength compared to broader indices like the S&P 500 and Dow Jones Industrial Average which fell significantly.
Risk Factors
  • Shares of Elevance Health Inc. (ELV) fell 2.67% to $286.39, recording a second consecutive day of losses in the stock.
  • The decline occurred during an all-around rough trading session where broader indices like the S&P 500 dropped 1.67% and the Dow Jones Industrial Average fell 1.73%.
Full Analysis
Shares of Elevance Health Inc. (ELV) experienced a decline on Friday, March 27, 2026, slipping 2.67% to settle at $286.39, marking its second consecutive day of losses. Despite the company's outperformance relative to competitors mentioned in the headline, the broader market conditions contributed to the downturn for this healthcare sector stock. The trading session was characterized by a significant sell-off across major indices, with the S&P 500 Index (SPX) falling 1.67% to close at 6,368.85 and the Dow Jones Industrial Average (DJIA) dropping 1.73% to 45,166.64. All market data reported reflects trades through Nasdaq only and is delayed by at least 15 minutes or according to specific exchange requirements. The article notes that Elevance Health Inc. was supported by world-class markets data provided by Dow Jones and FactSet during the trading period. Additionally, MarketWatch Automation, which partners with Automated Insights, facilitated the delivery of this latest content regarding the stock's performance at record speed and with stated accuracy. This reporting underscores the integration of advanced data partnerships to maintain up-to-the-minute coverage for investors tracking Elevance Health Inc.'s movements amid broader market volatility. MarketWatch retains copyright over the 2026 publication of these financial updates, ensuring that all rights are reserved. The provided intraday and historical end-of-day data, sourced from FACTSET, remains subject to specific terms of use applicable to the platform's information services. As of Friday afternoon at 4:46 p.m. ET, the stock closed lower within a negative sentiment environment affecting the wider S&P 500 benchmark, illustrating the challenges faced by individual equities even when they may be outperforming their peer groups on a relative basis.